Low-dose lithium for the treatment of behavioral symptoms in frontotemporal dementia
Treatment of Behavioral Symptoms in Frontotemporal Dementia
Sponsor: Alzheimer's Drug Discovery Foundation
Enrolling: Male and Female Patients
Study Length: 12 Weeks
Clinic Visits: 7
IRB Number: 7310
U.S. Govt. ID: NCT02862210
Contact: Hannah Silverman: 2123056284 / hs2971@cumc.columbia.edu
Additional Study Information: The purpose of this study is to better understand how to manage behavioral symptoms of frontotemporal dementia over time. These symptoms include agitation, aggression, and repetitive behaviors. During the study, we will give the participant low doses of lithium carbonate, or a placebo (sugar pill). Over the course of three months, the participant will come in every two weeks with a study partner, who may be a family member or friend, for medical assessment. Each visit will last 1-2 hours. Participation and transportation costs will be reimbursed.
This study is closed
Edward Huey, MD
Do You Qualify?
Do you have a diagnosis of dementia? Yes No
Do you have a study partner who can accompany you during visits? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Hannah Silverman